
Cardiovascular disease fellow @Wayne cardio | former CMR @ Trinity Health Ann Arbor | Interested in clinical electrophysiology + MedEd #cardiorounds
United States
Joined July 2025
- Tweets119
- Following67
- Followers436
- Likes20
Emmanuel Daniel retweeted
🫀M-mode findings in severe AR
• 〰️ AML fluttering: fine diastolic vibration of the AML as the AR jet hits it.
• ⏱️ Premature MV closure: the mitral valve closes before the QRS in acute severe AR
• Dilated LV: LVIDd and LVIDs enlarge in chronic severe AR.
#cardiorounds
Emmanuel Daniel retweeted
The reason why Trump is president is because the US has way too many people like this.
Trump fans in Oklahoma: "He's gonna fix it. Believe in him, stand strong ... all the abortion, it's evil. That's one thing that Trump stands for is us Christians. We're being killed everywhere. I want to see two people -- Trump and Jesus ... we do not want Muslims taking over ... I have horrible thoughts. I don't think they should be here. This isn't their country ... they need to pack up their stuff and go back to where they came from."
Emmanuel Daniel retweeted
The day after the announcement of the neutral results of HORIZON Lp(a), and while keeping in mind that nobody has yet seen the final results (although, in practical and regulatory terms, that may matter little), much of the discussion is focusing on Lp(a) as a prognostic risk-stratification marker.
The argument goes: “If you, as a patient, have high Lp(a), then you are a high-risk patient, and I will intensify the therapies I have available”—starting from the assumption that, without knowing your Lp(a), I would somehow not have done so based on other available biomarkers and clinical features.
But this raises at least two other questions.
First: what therapy has evidence specifically in patients with elevated Lp(a)? Are there trials of non-Lp(a)-lowering drugs conducted specifically in patients with elevated Lp(a) (all patients, not just a subgroup—no cheating)?
Second: if universal Lp(a) screening is indeed useful even though we have no evidence that lowering Lp(a) improves outcomes, are there at least studies showing that knowing the Lp(a) level improves outcomes? In other words, are there trials in which physicians—not patients—are randomized to know versus not know the Lp(a) value, and therefore to act accordingly (e.g., prescribing exercise or other therapies that physicians in the control group would presumably consider anyway)?
Emmanuel Daniel retweeted
I'm absolutely shocked by the Novartis LP(a) ASO flop. The genetic and epidemiological data for this approach could not have been more of a slam dunk. Are there any smart cardiologist/lipidologists out there who can possibly explain why this failed?
Biology is humbling.
Emmanuel Daniel retweeted
Perfect timing—and a bit of a cruel twist, one might say. In a week, CHAMPION-AF may tell a different story, but the long-awaited CLOSURE-AF, now out in @NEJM, makes for a tough week ahead for those supporting left atrial appendage closure. nejm.org/doi/full/10.1056/NE…
Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE…
Emmanuel Daniel retweeted
Long-Term Outcomes of the DanGer Shock Trial: @NEJM
🥸 DanGer ~ #ESCCongress2025
Emmanuel Daniel retweeted
Do NOT combine Aspirin and OAC for long-term use - not even in patients at high ASCVD risk!
#AQUATIC confirms for 🇪🇺 patients what has been shown before in East Asian patients.
@escardio #ESCCongress2025
nejm.org/doi/full/10.1056/NE…
Emmanuel Daniel retweeted
Congratulations to Jacob and the Danger Shock team, at #ESC2025 they shared long terms outcomes from the trial, demonstrating persistent benefits of Impella in AMI-CS out to 10 years of follow up.
Emmanuel Daniel retweeted
Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes: @NEJM
🥸 The slow decline of aspirin: #ESCCongress2025
😱 Here is the summary of the NEO-MINDSET Trial
👇👇👇
Emmanuel Daniel retweeted
Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis ahajournals.org/doi/10.1161/…
Emmanuel Daniel retweeted
Love our mentoring sessions with the next generation of cardiologists. ❤️Our 17th year of #CVBootCamp25! 50 cardiology fellows from throughout the US. Thank you @NadeenFaza and @HMethodistCV
@ACCinTouch @ASE360 @SCMR @Heart_SCCT @escardio @MyASNC @DrMarthaGulati
The #CVBootCamp25 Mentorship Lunch was a success! First-year fellows had the chance to connect with cardiology experts, gaining key advice on training, career direction, and subspecialties. Big thanks to our mentors: @WilliamZoghbi @CASivaram1 @DipanJShah @ShadenKhalaf @sitagarapati @kershawpatel @AmitGoyalMD @AlpeshShahMD @dr_chebrolu @mahwash_kassi @ahmsolmd Drs Parekh and Artimi!
#ACCFIT #CardioX #Cardiotwitter
Emmanuel Daniel retweeted
Unstable angina patients with elevated #hsCRP levels (≥3 mg/L) are associated with sustained proinflammatory reprogramming of circulating monocytes, which contributes to residual inflammation and increased CV risk. jacc.org/doi/10.1016/j.jacbt…
#JACCBTS #ASCVD #cvCAD
Emmanuel Daniel retweeted
This is SO COOL! New in @JACCJournals #JACCHF: HF-AI software system that integrates HF guidelines & pt info improved GDMT usage & provided follow-up & lab recs similar to those of cardiologists. >80% of changes without an in-person visit! #GDMTworks #AI @GCFMD, @MKittlesonMD @slumberbell @adrianjdasilva @Nikhil15 @docbhardwaj @MHBeasleyMD @giorgia_benzoni @MunirJanmohamed @SaraInglisMBBCh
jacc.org/doi/10.1016/j.jchf.…
Emmanuel Daniel retweeted
Only 4 More Days Until…
🎙️SoCCC Podcast #1🎙️
Breaking Down VT Storm: Life-Saving Tips for ICU and CICU Physicians with @ElliottMillerMD
If you're a critical care clinician who wants to be prepared when seconds count, this one's for you!🔥
#SoCCC #PodcastLaunch #CriticalCare #VTStorm #ICU #CICU #LifeSavingTips
@JasonKatzMD @BalimSenmanMD @AnnGageMD @jameshorowitzmd @CourtneyRCronin @CCCEnthusiasts
Emmanuel Daniel retweeted
Welcome to our July 16 issue of #JACCCaseReports @JACCJournals, with a mini-focus on the #tricuspid valve! See our articles with links below.
jacc.org/journal/case-report…
Full PDF here:
jacc.org/doi/10.1016/S2666-0…
Video summary here:
youtu.be/Vul56Cg7yvc
Congrats to our Associate Editor @AndreaScotti21 for his excellent Editor’s Page:
Transcatheter Tricuspid Valve Intervention: Where Do We Stand?
jacc.org/doi/10.1016/j.jacca…
Mini-Focus on Tricuspid Valve
Coronary Sinus Pacing After Tricuspid Valve Intervention: Single Center Case Series
jacc.org/doi/10.1016/j.jacca…
Transcatheter Tricuspid Valve Replacement After Failed Transcatheter Annuloplasty and Edge-to-Edge Repair
jacc.org/doi/10.1016/j.jacca…
Transcatheter Tricuspid Valve Replacement for Recurrent Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair
jacc.org/doi/10.1016/j.jacca…
Ultraslow Thrombolysis of Mechanical Tricuspid Prosthetic Thrombosis
jacc.org/doi/10.1016/j.jacca…
Comprehensive Care Approach to Drug-Related Tricuspid Valve Endocarditis Using Percutaneous Vegectomy
jacc.org/doi/10.1016/j.jacca…
Incidental Finding of Vieussens' Collaterals in Tricuspid Regurgitation Due to Infective Endocarditis
jacc.org/doi/10.1016/j.jacca…
Ruptured Sinus of Valsalva Aneurysm (SOVA) With Aorto-Atrial Fistula Mimicking Tricuspid Valve Endocarditis
jacc.org/doi/10.1016/j.jacca…
Clip Liberation to Facilitate Transcatheter Tricuspid Valve Replacement (CLEFT)
jacc.org/doi/10.1016/j.jacca…
Flail Tricuspid and Mitral Valve in Neonatal Lupus
jacc.org/doi/10.1016/j.jacca…
Wire-Based Interventional Clip Excision (WICE Procedure) to Allow Transcatheter Tricuspid Valve Replacement
jacc.org/doi/10.1016/j.jacca…
Emergent Transcatheter Tricuspid Edge-to-Edge Repair for Right Ventricular Shock From Tricuspid Regurgitation in Hypertrophic Cardiomyopathy
jacc.org/doi/10.1016/j.jacca…
Coronary, Peripheral and Structural Interventions
A Novel Wire-Assisted Percutaneous Mitral Commissurotomy
jacc.org/doi/10.1016/j.jacca…
Stent With Occluder in the Valve Commissure Technique for Transcatheter Mitral Valve Replacement
jacc.org/doi/10.1016/j.jacca…
Neo Left Main Creation and Percutaneous Closure of Left Coronary Button Pseudoaneurysm After Bentall Procedure
jacc.org/doi/10.1016/j.jacca…
Hand-Assisted Rotational Atherectomy for Severe and Long Superficial Femoral Artery Calcification: A Step-by-Step Guide
jacc.org/doi/10.1016/j.jacca…
Transcatheter Mitral Valve-in-Valve Replacement With Balloon-Assisted Translocation in Calcified Mitral Anterior Leaflet
jacc.org/doi/10.1016/j.jacca…
Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Left Atrial Appendage
jacc.org/doi/10.1016/j.jacca…
Valvular Heart Disease
Subclinical Delayed Coronary Ostial Obstruction After Transcatheter Aortic Valve Replacement With a High-Frame Transcatheter Valve
jacc.org/doi/10.1016/j.jacca…
Infective Endocarditis–Associated Glomerulonephritis With Cryoglobulin Positivity
jacc.org/doi/10.1016/j.jacca…
Native Triple-Valve Endocarditis Caused by Corynebacterium striatum Needing Urgent Surgery
jacc.org/doi/10.1016/j.jacca…
Transcatheter Edge-to-Edge Mitral Valve Repair Using PASCAL System for a Patient With Medial Commissure Flail
jacc.org/doi/10.1016/j.jacca…
Real-Time Leaflet Monitoring Using Intravascular Ultrasound During Transcatheter Aortic Valve Implantation
jacc.org/doi/10.1016/j.jacca…
Mechanical Aortic Valve Thrombosis: Treatment With Tissue Plasminogen Activator
jacc.org/doi/10.1016/j.jacca…
Heart Failure and Cardiomyopathies
Post-Transplant Lymphoproliferative Disorder Presenting as Biventricular Failure After Heart Transplantation
jacc.org/doi/10.1016/j.jacca…
A Tale of Two Zebras: Cardiac Intimal Sarcoma Discovered in a Male Patient With SCAD and ADPKD
jacc.org/doi/10.1016/j.jacca…
A Rare Case of Fulminant Myocarditis Leading to the Diagnosis of Systemic Lupus Erythematosus
jacc.org/doi/10.1016/j.jacca…
Multimodal Imaging Evaluation of Myocardial Involvement in Rare Oculoleptomeningeal Hereditary Transthyretin Amyloidosis
jacc.org/doi/10.1016/j.jacca…
A Case of Cutaneous Kaposi Sarcoma in a Patient Post–Heart Transplantation
jacc.org/doi/10.1016/j.jacca…
Patent Foramen Ovale Closure in a Patient With Ventricular Storm and Arrhythmogenic Right Ventricular Cardiomyopathy
jacc.org/doi/10.1016/j.jacca…
Challenges in Diagnosing Systemic Amyloidosis: A Case Report and Review of Literature
jacc.org/doi/10.1016/j.jacca…
@MinnowWalsh
@DeeDeeWangMD
@hmkyale
@Justine_Turco
@NAkhterMD
@aroniskn
@MiChen__
@FontanDoc
@juliendreyfus1
@sarano_maurice
@Miho_Fukui_
@Nishaki1
@ACHDocTMoe
@AdityaParikhMD
@AmitPawaleMD
@M_Pompeu_Sa_MD
@jsaef1
@JTSaxon
@Kentso987
@m_taramasso
@SyedZaidMD
Authors’ handles:
@Dhiran_Verghese
@aakriti_15
@emmy_dann
@MichaelGritti
@AminYehyaMD
@realnickvalle
@CarlosEVergaraU
@nkakouros
@MMarinCuartas
@razzorama
@enta_yusuke
@oshichan1031
@chrisgraeni
@MJHundertmark
@mnobremenezes
@rituyadav__
@DrKevinBuda
@FabricSoften_MD
@DineshKalra
@daisuke11sato
@BethDineenDO
@GiulioMonde
Emmanuel Daniel retweeted
Peripheral artery disease (PAD) affects more than 200 million people worldwide.
This JAMA Clinical Guidelines Synopsis summarizes the @ACCinTouch and @American_Heart’s 2024 guidelines on management of lower extremity PAD.
ja.ma/44yPQhz
































